
|Articles|May 28, 2009
Ranbaxy chief steps down
1 June 2009
Advertisement
Chairman and chief executive of Ranbaxy Laboratories, Malvinder Singh, has stepped down, handing more control over the generic drug maker to its Japanese owner Daiichi Sankyo.
Mr Singh's family founded the company and it has since become one of India's best-known multinational companies. He will be replaced as chief executive by Atul Sobti, currently the company's chief operating officer and Tsutomo Une, Daiichi's senior executive officer, will take over his responsibilities as chairman.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
From Value Imperative to Operating Reality: Rethinking Trust in Pharma
2
Pharma’s New Growth Equation: Smarter Deals, Stronger Science, Rising Costs
3
2026 Pharm Exec Top 50 Companies
4
Everything You Need to Know About the AstraZeneca–Bristol Myers Squibb Merger Rumors
5




